rAAV9-cMLCK

N/A

Report date: 2024/11/05 16:40:44

Base Information

Drug NamerAAV9-cMLCK
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMyosin light chain kinase 3 stimulants
TargetsMyosin light chain kinase 3
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZensun (Shanghai) Sci&Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZensun (Shanghai) Sci&Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A